Analyst firms · Oppenheimer · ARVN

Oppenheimer ARVN price target and rating history

Arvinas Inc. (ARVN) · Health Care

Oppenheimer rates Arvinas Inc. (ARVN) Perform with a $80 price target, as of its latest action on Mar 11, 2025. It has published 4 rating actions on ARVN since July 2021, including 0 upgrades and 1 downgrade.

Current rating
Perform
Price target
$80
Median target, all firms
Too few
Actions on ARVN
4

Oppenheimer price target on ARVN

$108$94$8020222023202420252026
Oppenheimer price target on ARVN, each point a stated target, July 2021 to February 2024.

Every Oppenheimer rating on ARVN

How other firms rate ARVN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoEqual WeightAug 4, 2026
CitigroupBuy$15Jan 6, 2026

Questions about Oppenheimer and ARVN

What is Oppenheimer's price target for ARVN?
Oppenheimer's latest stated price target for Arvinas Inc. (ARVN) is $80, from its action on Feb 28, 2024.
What is Oppenheimer's rating on ARVN?
Oppenheimer rates ARVN Perform, a neutral rating, as of Mar 11, 2025.
When did Oppenheimer last change its view on ARVN?
On Mar 11, 2025, Oppenheimer downgrades to Perform from Outperform.

More ARVN rating histories

All Oppenheimer ratingsARVN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.